Participants:18–64 years · 65+ years
Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Dermatitis atopic

Recruiting

Registered drug

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Systemic scleroderma

Recruiting

Investigational

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Obesity

Recruiting

Investigational

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drugNo placebo

A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Find therapies in clinical trials near you – page 3

692 trials match your criteria

Metabolic dysfunction-associated liver disease

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Hepatic cirrhosis

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Breast cancer+1

Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

Coeliac disease

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Dermatitis atopic

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Type 2 diabetes mellitus

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Type 2 diabetes mellitus

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Systemic scleroderma

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Hormone receptor positive HER2 negative breast cancer

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Obesity

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Type 2 diabetes mellitus

A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.